Today’s drug discovery demands more than scientific excellence—it requires seamless collaboration across disciplines to make faster, smarter decisions.
Join Sai Life Sciences for an expert panel discussion on how Integrated Drug Discovery (IDD) brings together biology, medicinal chemistry, DMPK, and project management within a unified framework to accelerate discovery programs and improve the probability of success.
About the Webinar
Drug discovery is a complex, iterative process where every scientific decision influences the next. Yet, many discovery programs still operate across fragmented workflows, creating communication gaps, delays, and increased development risk.
An Integrated Drug Discovery (IDD) approach addresses these challenges by bringing together multidisciplinary expertise from the earliest stages of discovery. By combining biology, medicinal chemistry, DMPK, and project management into a single, collaborative team, organizations can make data-driven decisions faster, optimize compounds more efficiently, and accelerate progression from target identification to development candidate selection.
In this webinar, experts from Sai Life Sciences will share how integrated scientific collaboration enables more informed decision-making throughout the discovery continuum, discuss the advantages of partnering through an IDD model, and explore practical strategies for overcoming common challenges in early drug discovery.
Meet the Speakers:
Mabi Jaleel,
Vice President – Biology
Leads Biology at Sai Life Sciences, advancing integrated drug discovery programs from target validation to candidate selection.
Santosh Kulkarni,
Vice President – Medicinal Chemistry
Heads Medicinal Chemistry, driving lead optimization and candidate development across discovery programs.
Vamsi Madgula,
Associate Vice President – DMPK
Leads DMPK and Toxicology Services, enabling informed candidate selection through ADMET and PK expertise.
Lakshmi Iyer,
Associate Vice President – Project Management
Leads Discovery Project Management, ensuring seamless execution and delivery of complex drug discovery programs.
Moderated By:
Victoria Steadman,
Head of Discovery, Business Development
Leads Discovery Business Development across Europe and APAC, supporting strategic partnerships and growth initiatives.
Topics We'll Cover
- What Integrated Drug Discovery really means—and why it matters
- How biology, medicinal chemistry, DMPK, and project management work together to accelerate discovery
- Advantages of integrated CRO partnerships over traditional service models
- Common challenges in integrated drug discovery and strategies to overcome them
- Best practices for improving collaboration, communication, and decision-making
- Future trends shaping integrated drug discovery